FIBRONECTIN

Last Updated on 12th April, 2024
5 minutes, 5 seconds

Description

FIBRONECTIN

Source: DownToEarth

Disclaimer: Copyright infringement not intended.

Context

  • A gene variant could lower chances of developing Alzheimer’s by 70%, could help in design of new treatments: Study.

Details

About the Study

  • Objective: Investigating why certain individuals with a high-risk gene variant (APOEε4) for Alzheimer’s disease remain protected from developing the condition.
  • Findings:
    • A mutated version of a gene responsible for fibronectin production reduces the risk of developing Alzheimer’s by 71%.
    • This fibronectin variant also delays disease onset by approximately four years in individuals who eventually develop Alzheimer’s.

Role of Fibronectin in Alzheimer’s

  • Blood-Brain Barrier (BBB) Function:
    • Fibronectin is a component of the BBB, which regulates the movement of substances into and out of the brain.
    • Maintaining the integrity of the BBB prevents the accumulation of amyloid beta protein in the brain, a hallmark of Alzheimer’s.
  • Protective Mechanism: The fibronectin variant identified in the study prevents the build-up of fibronectin, thereby preserving BBB function and facilitating amyloid clearance.

Implications for Treatment

  • Potential Therapeutic Target: Drugs that reduce excess fibronectin could offer protection against Alzheimer’s by maintaining BBB integrity and promoting amyloid clearance.
  • Drug Development: Identifying compounds that target fibronectin could lead to novel treatments for Alzheimer’s, potentially addressing the disease’s underlying pathology rather than just its symptoms.

About Fibronectin

  • It is a high-molecular-weight glycoprotein found in the extracellular matrix and circulating in the blood plasma.
  • It plays crucial roles in various biological processes, including cell adhesion, migration, growth, and differentiation.

Structure of Fibronectin:

  • Primary Structure:
    • Fibronectin is composed of repeating structural motifs called modules or domains.
    • It is encoded by a gene located on human chromosome 2.
  • Domain Structure:
    • Fibronectin contains multiple types of domains, including type I, type II, and type III repeats.
    • These repeats form distinct functional regions within the protein.
  • Glycosylation: Fibronectin undergoes post-translational modifications, including glycosylation, which affects its function and stability.
  • Alternative Splicing: Fibronectin can be alternatively spliced, resulting in different isoforms with distinct functions.

 

Functions of Fibronectin:

  • Cell Adhesion: Fibronectin binds to cell surface receptors such as integrins, facilitating cell adhesion to the extracellular matrix.
  • Extracellular Matrix Organization: Fibronectin contributes to the structural organization of the extracellular matrix, providing support and anchorage for cells.
  • Cell Signaling: Fibronectin-mediated interactions with cell surface receptors trigger intracellular signaling pathways, regulating various cellular processes.
  • Tissue Repair and Remodeling: Fibronectin plays a crucial role in wound healing, tissue regeneration, and remodeling processes.

Roles of Fibronectin in Health and Disease:

  • Development and Morphogenesis: Fibronectin is essential for embryonic development, including processes like gastrulation and tissue morphogenesis.
  • Wound Healing: Fibronectin facilitates the migration of cells to wound sites and promotes tissue repair by providing a scaffold for cell adhesion and proliferation.
  • Cancer Progression and Metastasis: Altered expression and function of fibronectin are associated with cancer progression, invasion, and metastasis.
  • Fibrosis: Fibronectin deposition contributes to the development of fibrosis in various organs, including the liver, lung, and kidney.

Research Applications of Fibronectin:

  • Cell Culture Substrate: Fibronectin-coated surfaces are commonly used in cell culture experiments to promote cell adhesion and proliferation.
  • Tissue Engineering: Fibronectin-based biomaterials are utilized in tissue engineering applications to mimic the natural extracellular matrix and promote tissue regeneration.
  • Drug Delivery: Fibronectin-targeting ligands are investigated for their potential use in targeted drug delivery systems, particularly for cancer therapy.
  • Disease Biomarker: Altered levels of fibronectin expression or isoform distribution are explored as potential biomarkers for various diseases, including cancer and fibrosis.

Must read article:

Alzheimer’s disease

Sources:

DownToEarth

PRACTICE QUESTION

Q.  Discuss the role of genetic variations in shaping individual susceptibility to neurodegenerative disorders. Provide examples from recent research to support your argument. (250 Words)

Free access to e-paper and WhatsApp updates

Let's Get In Touch!